ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 506,10
0,47%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) Actualités

PRTC

PureTech Health (PRTC)

PureTech Health PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateHeureSourceTitreSymboleSociété
13/06/202422h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
13/06/202419h15Business WirePureTech Health: Results of Annual General MeetingNASDAQ:PRTCPureTech Health PLC
06/06/202422h39Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PRTCPureTech Health PLC
06/06/202418h38Business WirePureTech Health: Result of General MeetingNASDAQ:PRTCPureTech Health PLC
30/05/202414h05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PRTCPureTech Health PLC
29/05/202414h09Business WirePureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyNASDAQ:PRTCPureTech Health PLC
23/05/202413h00Business WirePureTech to Present at the Jefferies Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
21/05/202413h05Business WirePureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile InfectionNASDAQ:PRTCPureTech Health PLC
20/05/202413h03Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:PRTCPureTech Health PLC
20/05/202408h00Business WirePureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareNASDAQ:PRTCPureTech Health PLC
09/05/202413h05Business WirePureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual MeetingNASDAQ:PRTCPureTech Health PLC
07/05/202413h05Business WirePureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive AppointmentsNASDAQ:PRTCPureTech Health PLC
25/04/202411h22Business WirePureTech Announces Annual Results for Year Ended December 31, 2023NASDAQ:PRTCPureTech Health PLC
18/04/202408h00Business WirePureTech Health: Notice of ResultsNASDAQ:PRTCPureTech Health PLC
16/04/202413h00Business WirePureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary FibrosisNASDAQ:PRTCPureTech Health PLC
11/04/202413h00Business WirePureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck CancersNASDAQ:PRTCPureTech Health PLC
09/04/202408h00Business WirePureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management TransitionsNASDAQ:PRTCPureTech Health PLC
19/03/202408h00Business WirePureTech Proposes $100 Million Capital ReturnNASDAQ:PRTCPureTech Health PLC
18/03/202414h52Business WireBristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 BillionNASDAQ:PRTCPureTech Health PLC
13/03/202412h00Business WirePureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid LeukemiaNASDAQ:PRTCPureTech Health PLC
27/02/202413h00Business WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
27/02/202408h00Business WirePureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in JapanNASDAQ:PRTCPureTech Health PLC
03/01/202413h00Business WirePureTech to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
22/12/202315h13Business WirePureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 BillionNASDAQ:PRTCPureTech Health PLC
20/12/202308h00Business WirePureTech Year End Update and Outlook for 2024NASDAQ:PRTCPureTech Health PLC
07/12/202312h00Business WirePureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023NASDAQ:PRTCPureTech Health PLC
29/11/202316h17Business WirePureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of SchizophreniaNASDAQ:PRTCPureTech Health PLC
17/11/202308h00Business WirePureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in SchizophreniaNASDAQ:PRTCPureTech Health PLC
14/11/202308h00Business WirePureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy VolunteersNASDAQ:PRTCPureTech Health PLC
11/10/202313h00Business WirePureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual MeetingNASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Dernières Valeurs Consultées

NASDAQ
AAPL
Apple
NASDAQ
NVDA
NVIDIA
EU
VK
Vallourec
EU
AF
Air FranceKLM
EU
RI
Pernod Ricard
EU
EN
Bouygues
EU
ACA
Credit Agricole
EU
ML
Michelin
EU
DG
Vinci
NASDAQ
AMZN
Amazon.com
NYSE
MCD
McDonalds
NYSE
JPM
JP Morgan Chase
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés